Royce & Associates’s BrightSpring Health Services BTSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.09M Sell
73,017
-37,009
-34% -$2.06M 0.04% 499
2026
Q1
$4.69M Sell
110,026
-37,513
-25% -$1.51M 0.05% 475
2025
Q4
$5.53M Sell
147,539
-34,999
-19% -$1.17M 0.06% 447
2025
Q3
$5.4M Buy
182,538
+44,505
+32% +$1.03M 0.05% 455
2025
Q2
$3.26M Buy
138,033
+90,020
+187% +$1.88M 0.03% 535
2025
Q1
$869K Buy
+48,013
New +$943K 0.01% 682

Other funds holding BTSG

Royce & Associates's BTSG Position: Q2 2026 in Review

Royce & Associates reduced its BrightSpring Health Services (BTSG) stake by 34% in Q2 2026, selling an estimated $2.06M and leaving 73,017 shares worth $5.09M. The position accounts for 0.04% of the portfolio, ranked #499.

Royce & Associates first reported a position in BTSG in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.53M in Q4 2025. 421 funds tracked by Wall St. Rank hold BTSG as of Q2 2026.

  • Royce & Associates held 73,017 shares of BrightSpring Health Services worth $5.09M as of Q2 2026.
  • Royce & Associates sold 37,009 BrightSpring Health Services shares in Q2 2026, an estimated $2.06M.
  • BrightSpring Health Services made up 0.04% of Royce & Associates's portfolio in Q2 2026, its #499 holding.
  • Royce & Associates first reported a position in BrightSpring Health Services in Q1 2025 and has held it in 6 quarters since.
  • Royce & Associates's BrightSpring Health Services position peaked at $5.53M in Q4 2025.
  • 421 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.